Get an email when this journal's indexing changes
Added to or removed from Scopus, Web of Science, ABDC, DOAJ, FT50, UT Dallas or ONOS. One confirmation click; unsubscribe anytime.
Trends in Cancer is Scopus-indexed (Q1, CiteScore 30.8), WoS SCIE. It is covered by India's One Nation One Subscription scheme for reading access. Published by Cell Press.
Checked against the index lists dated .
ISSN 2405-8025Verify ISSN ↗2405-8033Verify ISSN ↗
Publisher: Cell Press
Cost to publish: About US$7,030 to publish open access (publisher list price, via OpenAlex) — subscription publishing may be free
| Subject area | Rank | Pctile | Q |
|---|---|---|---|
| Oncology | 14 / 428 | 96th | Q1 |
| Cancer Research | 11 / 233 | 95th | Q1 |
Not listed in: DOAJ, ABDC, ABS / AJG, FT50, UT Dallas, ONOS (APC covered)
Yes — actively indexed in Scopus, coverage 2015–present, best quartile Q1, CiteScore 30.8.
Trends in Cancer is Q1 in Oncology (rank 14 of 428) and Q1 in Cancer Research (rank 11 of 233), by CiteScore 2025.
Trends in Cancer is indexed in the Science Citation Index Expanded, so it may have a Journal Impact Factor in Clarivate's Journal Citation Reports. JCR is paid, so check it for the current value. The closest free measure is its Scopus CiteScore 30.8, which places it in quartile Q1 at the 96th percentile of its subject. Its SCImago Journal Rank (SJR, a free Scopus-based metric) is 5.488, quartile Q1, with an H-index of 116.
The publisher lists an article processing charge of about US$7,030 for open access (source: OpenAlex). Many journals also publish by the subscription route at no cost to the author, so confirm on the journal's own website.
Trends in Cancer is published by Cell Press. Its print ISSN is 2405-8025 and its online ISSN is 2405-8033.
Yes. It is part of the One Nation One Subscription (ONOS) national subscription, so readers at participating Indian institutions get its full text. ONOS does not cover its article processing charge.
Yes — indexed in the Science Citation Index Expanded.
No — it is not registered as an open-access journal in DOAJ or Scopus.
Trends in Cancer has an h-index of 140 and a 2-year mean of 10.89 citations per paper (OpenAlex). Its Scopus CiteScore is 30.8, quartile Q1. On 2-year citations it ranks #16 of 424 Scopus journals in Oncology.
Trends in Cancer published 142 papers in 2025; its busiest recent year was 2020 with 173. 2026* is the year so far.
h-index, i10-index and 2-year mean citedness are open, licence-clear metrics from OpenAlex — not a proprietary impact factor. The subject rank counts only journals that OpenAlex has a figure for; it is not a Scopus or Clarivate ranking. Updated 2026-10-14.
In its latest 85 research articles (2026), authors are most often from United States (41.2%), China (15.1%) and France (7.8%).
Countries are counted fractionally, so a paper by authors from two countries counts half to each.
Scopus status: Active. 1 retracted paper is recorded (0.7 per 1,000 papers). The Problematic Paper Screener flags none of its papers. These are indicators to check, not findings against the journal.
Retractions from OpenAlex; flags from the Problematic Paper Screener (Cabanac, Labbé & Magazinov, CC BY), 2026-09-21 export. A flag marks a paper for a closer look; it is not a finding against the journal.
Index data is curated from public sources (Scopus, Web of Science, ABDC, FT50, UT Dallas, DOAJ). CiteScore and quartiles reflect the latest available Scopus release. Always verify a journal's current status on its official source before submitting.
Comments load as you scroll here.